Jane Street Group, LLC Xeris Biopharma Holdings, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$3.95 - $5.16 $20,935 - $27,348	5,300 Added 40.46%	18,400 $85,000
Q1 2025 May 14, 2025	BUY	$3.2 - $5.95 $41,920 - $77,945	13,100 New	13,100 $71,000
Q1 2022 May 17, 2022	SELL	$2.0 - $2.87 $212,400 - $304,794	-106,200 Reduced 55.03%	86,800 $222,000
Q4 2021 Feb 15, 2022	BUY	$1.8 - $2.93 $347,400 - $565,490	193,000 New	193,000 $565,000

207

89.4M

81.6K

57.6K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $1.14B
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.